AP3609A - New process for the synthesis of agomelatine - Google Patents

New process for the synthesis of agomelatine

Info

Publication number
AP3609A
AP3609A AP2013007022A AP2013007022A AP3609A AP 3609 A AP3609 A AP 3609A AP 2013007022 A AP2013007022 A AP 2013007022A AP 2013007022 A AP2013007022 A AP 2013007022A AP 3609 A AP3609 A AP 3609A
Authority
AP
ARIPO
Prior art keywords
agomelatine
synthesis
new process
new
Prior art date
Application number
AP2013007022A
Other languages
English (en)
Other versions
AP2013007022A0 (en
Inventor
Samir Zard
Béatrice Sire
Medhi Boumediene
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44088993&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3609(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Publication of AP2013007022A0 publication Critical patent/AP2013007022A0/xx
Application granted granted Critical
Publication of AP3609A publication Critical patent/AP3609A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/06Preparation of carboxylic acid amides from nitriles by transformation of cyano groups into carboxamide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/02Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/37Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/01Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/40Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2013007022A 2011-01-05 2012-01-04 New process for the synthesis of agomelatine AP3609A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1100024A FR2970000B1 (fr) 2011-01-05 2011-01-05 Nouveau procede de synthese de l'agomelatine
PCT/FR2012/000005 WO2012113999A1 (fr) 2011-01-05 2012-01-04 Procede et intermediaires de synthese de l ' agomelatine

Publications (2)

Publication Number Publication Date
AP2013007022A0 AP2013007022A0 (en) 2013-07-31
AP3609A true AP3609A (en) 2016-02-26

Family

ID=44088993

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013007022A AP3609A (en) 2011-01-05 2012-01-04 New process for the synthesis of agomelatine

Country Status (43)

Country Link
US (2) USRE46218E1 (xx)
EP (1) EP2661422B9 (xx)
JP (1) JP5837616B2 (xx)
KR (1) KR101543432B1 (xx)
CN (1) CN103313965B (xx)
AP (1) AP3609A (xx)
AR (1) AR084780A1 (xx)
AU (1) AU2012220474B2 (xx)
BR (1) BR112013017307A2 (xx)
CA (1) CA2823587C (xx)
CL (1) CL2013001882A1 (xx)
CO (1) CO6731101A2 (xx)
CR (1) CR20130301A (xx)
CU (1) CU24289B1 (xx)
CY (1) CY1117774T1 (xx)
DK (1) DK2661422T3 (xx)
EA (1) EA022077B1 (xx)
EC (1) ECSP13012735A (xx)
ES (1) ES2583682T3 (xx)
FR (1) FR2970000B1 (xx)
GE (1) GEP20156365B (xx)
HK (1) HK1189571A1 (xx)
HR (1) HRP20160713T1 (xx)
HU (1) HUE028471T2 (xx)
IL (1) IL227281A (xx)
JO (1) JO3200B1 (xx)
ME (1) ME02408B (xx)
MX (1) MX2013007837A (xx)
MY (1) MY162977A (xx)
NI (1) NI201300062A (xx)
PE (1) PE20140037A1 (xx)
PL (1) PL2661422T3 (xx)
RS (1) RS54753B9 (xx)
RU (1) RU2550812C2 (xx)
SA (1) SA112330134B1 (xx)
SG (1) SG191733A1 (xx)
SI (1) SI2661422T1 (xx)
TN (1) TN2013000274A1 (xx)
TW (1) TWI438180B (xx)
UA (1) UA104122C2 (xx)
UY (1) UY33845A (xx)
WO (1) WO2012113999A1 (xx)
ZA (1) ZA201305027B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103058879B (zh) * 2012-12-20 2015-09-09 安徽悦康凯悦制药有限公司 阿戈美拉汀的制备方法
CN103804232B (zh) * 2014-01-26 2015-08-19 江西同和药业股份有限公司 一种1-氰基-1-(7-甲氧基-3,4-二氢-1-萘基)甲醇酯类化合物及其制备方法和应用
CN107353229B (zh) * 2017-08-08 2019-04-30 许昌恒生制药有限公司 一种阿戈美拉汀中间体的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447285A1 (fr) * 1990-02-27 1991-09-18 Adir Et Compagnie Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP1564202A1 (fr) * 2004-02-13 2005-08-17 Les Laboratoires Servier Nouveau procédé de synthèse et nouvelle forme cristalline de l'agomelatine ainsi que les compositions pharmaceutiques qui la contiennent

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866334B1 (fr) 2004-02-13 2006-05-26 Servier Lab Nouveau procede de synthese du (7-methoxy-1-naphtyl) acetonitrile et application a la synthese de l'agomelatine
CN101486665B (zh) 2009-03-03 2013-04-17 上海医药工业研究院 阿戈美拉汀中间体2-(7-甲氧基-1-萘基)乙酰胺的制备方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0447285A1 (fr) * 1990-02-27 1991-09-18 Adir Et Compagnie Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP1564202A1 (fr) * 2004-02-13 2005-08-17 Les Laboratoires Servier Nouveau procédé de synthèse et nouvelle forme cristalline de l'agomelatine ainsi que les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
CU24289B1 (es) 2017-12-08
HK1189571A1 (en) 2014-06-13
EP2661422A1 (fr) 2013-11-13
CA2823587C (fr) 2015-11-24
UA104122C2 (uk) 2013-12-25
TWI438180B (zh) 2014-05-21
EP2661422B9 (fr) 2016-09-07
ECSP13012735A (es) 2013-09-30
CY1117774T1 (el) 2017-05-17
EA201300794A1 (ru) 2014-02-28
RS54753B1 (sr) 2016-10-31
WO2012113999A8 (fr) 2013-08-01
CL2013001882A1 (es) 2013-12-06
CN103313965A (zh) 2013-09-18
AP2013007022A0 (en) 2013-07-31
HRP20160713T1 (hr) 2016-07-29
NZ612173A (en) 2015-08-28
FR2970000A1 (fr) 2012-07-06
JP2014509309A (ja) 2014-04-17
JO3200B1 (ar) 2018-03-08
FR2970000B1 (fr) 2013-01-04
CO6731101A2 (es) 2013-08-15
UY33845A (es) 2012-07-31
SG191733A1 (en) 2013-08-30
PE20140037A1 (es) 2014-02-01
CR20130301A (es) 2013-08-08
RU2550812C2 (ru) 2015-05-20
RU2013136344A (ru) 2015-02-10
KR20130115345A (ko) 2013-10-21
AU2012220474A1 (en) 2013-07-11
USRE46218E1 (en) 2016-11-29
MY162977A (en) 2017-07-31
ES2583682T9 (es) 2016-10-31
JP5837616B2 (ja) 2015-12-24
CN103313965B (zh) 2015-08-05
TN2013000274A1 (fr) 2014-11-10
TW201309623A (zh) 2013-03-01
HUE028471T2 (en) 2016-12-28
PL2661422T3 (pl) 2016-10-31
RS54753B9 (sr) 2019-09-30
KR101543432B1 (ko) 2015-08-10
WO2012113999A1 (fr) 2012-08-30
EA022077B1 (ru) 2015-10-30
NI201300062A (es) 2013-12-11
EP2661422B1 (fr) 2016-04-20
CU20130092A7 (es) 2013-08-29
ES2583682T3 (es) 2016-09-21
CA2823587A1 (fr) 2012-08-30
US8853449B2 (en) 2014-10-07
SI2661422T1 (sl) 2016-08-31
GEP20156365B (en) 2015-09-10
MX2013007837A (es) 2013-09-06
AR084780A1 (es) 2013-06-26
IL227281A (en) 2015-06-30
ZA201305027B (en) 2014-03-26
ME02408B (me) 2016-09-20
SA112330134B1 (ar) 2014-08-25
AU2012220474B2 (en) 2015-08-20
BR112013017307A2 (pt) 2016-10-04
IL227281A0 (en) 2013-09-30
DK2661422T3 (en) 2016-10-24
US20130289307A1 (en) 2013-10-31

Similar Documents

Publication Publication Date Title
PL2531286T3 (pl) Sposób syntezy metanolu
PT2875062T (pt) Processo de síntese de poliarilétercetonas
IL220936A0 (en) Process for the synthesis of lacosamide
IL229647A0 (en) A new process for the preparation of prostaglandin amides
SG11201400939YA (en) Process for the preparation of methoxymelonal
HK1198584A1 (en) Process for the preparation of travoprost
IL232735A0 (en) A process for purifying polyaminocarboxylates
AP3609A (en) New process for the synthesis of agomelatine
EP2757158A4 (en) ENZYMATIC PROCESS FOR ESTOLIDE SYNTHESIS
HRP20160767T1 (hr) Postupak za pripremu kristalnog oblika i agomelatina
GB201111381D0 (en) Process for the synthesis of prodrugs of opioids
AP3399A (en) New process for the synthesis of agomelatine
PT2739610T (pt) Processo para o fabrico de ivabradina e de produtos intermédios para a sua síntese
HUP1100291A2 (en) Process for the preparation of prostaglandin amides
GB201111386D0 (en) Process for the synthesis of prodrugs of opioids
PL394565A1 (pl) Sposób otrzymywania niklowanych katalizatorów metanizacji
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
PL2710014T3 (pl) Sposób syntezy rifaksyminy